Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro

Human Gene Therapy

Volumn 9, Issue 9, 1998, Pages 1335-1344

  Imro, Maria Adele ^a   Dellabona, Paolo ^a   Manici, Simona ^a   Heltai, Silvia ^a   Consogno, Giuseppe ^a   Bellone, Matteo ^a   Rugarli, Claudio ^a,b   Protti, Maria Pia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; COMPLEMENTARY DNA; HLA ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOID CELL LINE; MELANOMA CELL; T LYMPHOCYTE ACTIVATION;

EID: 0032503676     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.9-1335     Document Type: Article

References (15)

1. ARIENTI, F., SULE'-SUSO, J., MELANI, C., MACCALLI, C., BELLI, F., ILLENI, M.T., ANICHINI, A., CASCINELLI, N., COLOMBO, M., and PARMIANI, G. (1994). Interleukin-2 genetransduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. Hum. Gene Ther. 5, 1139-1150.
2. ARIENTI, F., SULE'-SUSO, J., BELLI, F., MASCHERONI, L., RIVOLTINI, L., MELANI, C., MAIO, M., CASCINELLI, N., COLOMBO, M.P., and PARMIANI, G. (1996). Limited anti-tumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells. Hum. Gene Ther. 7, 1955-1963.
3. BLUESTONE, J.A. (1995). New perspective of CD28-B7-mediated T cell costimulation. Immunity 2, 555-559.
4. L. Immunity 3, 87-98.
5. BOISE, L.H., NOEL, P.J., and THOMPSON, C.B. (1995). CD28 and apoptosis. Curr. Opin. Immunol, 7, 620-625.
6. BOON, T., CEROTTINI, J.C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., and VAN PEL, A. (1994). Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12, 337-365.
7. CAVALLO, F., MARTIN-FONTECHA, A., BELLONE, M., HELTAI, S., GATTI, E., TORNAGHI, P., FRESCHI, M., FORNI, G., DELLABONA, P., and CASORATI, G. (1995). Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 25, 1154-1162.
8. CHEN, L., ASHE, S., BRADY, W.A., HELLSTROM, I., HELLSTROM, K.E., LEDBETTER, J.A., MCGOVAN, P., and LINSLEY, P.S. (1992). Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102.
9. CHEN, L., LINSLEY, P.S., and HELLSTROM, K.E. (1993). Costimulation of T cells or tumor immunity. Immunol. Today. 14, 483-486.
10. COLOMBO, M.P., and FORNI, G. (1994). Cytokine gene transfer in tumor inhibition and tentative tumor therapy: Where are we now? Immunol. Today 15, 48-51.
11. DOHRING, C., ANGMAN, L., SPAGNOLI, G., and LANZAVECCHIA, A. (1994). T-helper and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J. Cancer 57, 754-759.
12. GIMMI, C.D., FREEMAN, G.J., GRIEBEN, J.G., GRAY, G., and NADLER, L.M. (1993). Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA. 90, 6586-6590.
13. IEZZI, G., PROTTI, M.P., RUGARLI, C., and BELLONE, M. (1996). B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines. Cancer Res. 56, 11-15.
14. LANE, P., GERHARD, W., HUBELE, S., LANZAVECCHIA, A., and CONNELL, M.C. (1993). Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1. Immunology 80, 56-61.
15. MARTIN-FONTECHA, A., CAVALLO, F., BELLONE, M., HELTAI, S., IEZZI, G., TORNAGHI, P., NABAVI, N., FORNI, G., DELLABONA, P., and CASORATI, G. (1996). Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors. Eur. J. Immunol. 26, 1851-1860.